Africa HIV Treatment Drugs Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	120 Pages	TechNavio	November, 2022	INF17509668

Best Price Guarantee
Price	from $2,500
Length	120 Pages
Publisher	TechNavio
Published Date	November, 2022
SKU	INF17509668

HIV Treatment Drugs Market in Africa 2023-2027

Technavio has been monitoring the HIV treatment drugs market in Africa and it is poised to grow by $321.6 mn during 2023-2027, accelerating at a CAGR of 3.76% during the forecast period. Our report on the HIV treatment drugs market in Africa provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of STDs, favorable international programs, and government collaborations.

Technavio's HIV treatment drugs market in Africa is segmented as below:

By Drug Class

Reverse transcriptase inhibitors
Protease inhibitors
Integrase inhibitors
Fusion inhibitors
Coreceptor antagonists

By Route of Administration

Oral drugs
Injectable drugs

By Geography

South Africa
Nigeria
Kenya
Uganda
Rest of Africa

This study identifies the increase in awareness by various organizations as one of the prime reasons driving the HIV treatment drugs market growth in Africa during the next few years. Also, the growing focus on elimination of mother-to-child transmission of HIV and high HIV drug resistance will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on HIV treatment drugs market in Africa covers the following areas:

HIV treatment drugs market sizing
HIV treatment drugs market forecast
HIV treatment drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading HIV treatment drugs market vendors that include Abbott Laboratories, AbbVie Inc., Alpha Pharma, Aspen Pharmacare Holdings Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Avacare Health, Boehringer Ingelheim International GmbH, Cipla Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hetero Labs Ltd., Johnson and Johnson, Merck and Co. Inc., SSI Diagnostica AS, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Theratechnologies Inc., and Viatris Inc. Also, the HIV treatment drugs market in Africa analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Country Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Drug Class
  - Table Executive Summary – Chart on Market Segmentation by Route of Administration
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Africa - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Regional - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Africa: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Historic Market Size
- HIV treatment drugs market in Africa 2017 - 2021
  - Table Historic Market Size – data Table on HIV treatment drugs market in Africa 2017 - 2021 ($ million)
- Drug Class Segment Analysis 2017 - 2021
  - Table Historic Market Size – Drug Class Segment 2017 - 2021 ($ million)
- Route Of Administration Segment Analysis 2017 - 2021
  - Table Historic Market Size – Route Of Administration Segment 2017 - 2021 ($ million)
- Country Segment Analysis 2017 - 2021
  - Table Historic Market Size – Country Segment 2017 - 2021 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Drug Class
- Market segments
  - Table Chart on Drug Class - Market share 2022-2027 (%)
  - Table Data Table on Drug Class - Market share 2022-2027 (%)
- Comparison by Drug Class
  - Table Chart on Comparison by Drug Class
  - Table Data Table on Comparison by Drug Class
- Reverse transcriptase inhibitors - Market size and forecast 2022-2027
  - Table Chart on Reverse transcriptase inhibitors - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Reverse transcriptase inhibitors - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Reverse transcriptase inhibitors - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Reverse transcriptase inhibitors - Year-over-year growth 2022-2027 (%)
- Protease inhibitors - Market size and forecast 2022-2027
  - Table Chart on Protease inhibitors - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Protease inhibitors - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Protease inhibitors - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Protease inhibitors - Year-over-year growth 2022-2027 (%)
- Integrase inhibitors - Market size and forecast 2022-2027
  - Table Chart on Integrase inhibitors - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Integrase inhibitors - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Integrase inhibitors - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Integrase inhibitors - Year-over-year growth 2022-2027 (%)
- Fusion inhibitors - Market size and forecast 2022-2027
  - Table Chart on Fusion inhibitors - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Fusion inhibitors - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Fusion inhibitors - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Fusion inhibitors - Year-over-year growth 2022-2027 (%)
- Coreceptor antagonists - Market size and forecast 2022- 2027
  - Table Chart on Coreceptor antagonists - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Coreceptor antagonists - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Coreceptor antagonists - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Coreceptor antagonists - Year-over-year growth 2022-2027 (%)
- Market opportunity by Drug Class
  - Table Market opportunity by Drug Class ($ million)
Market Segmentation by Route of Administration
- Market segments
  - Table Chart on Route of Administration - Market share 2022-2027 (%)
  - Table Data Table on Route of Administration - Market share 2022-2027 (%)
- Comparison by Route of Administration
  - Table Chart on Comparison by Route of Administration
  - Table Data Table on Comparison by Route of Administration
- Oral drugs - Market size and forecast 2022-2027
  - Table Chart on Oral drugs - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Oral drugs - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Oral drugs - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Oral drugs - Year-over-year growth 2022-2027 (%)
- Injectable drugs - Market size and forecast 2022-2027
  - Table Chart on Injectable drugs - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Injectable drugs - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Injectable drugs - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Injectable drugs - Year-over-year growth 2022-2027 (%)
- Market opportunity by Route of Administration
  - Table Market opportunity by Route of Administration ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography - 2022-2027 (%)
  - Table Data Table on Market share by geography - 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- South Africa - Market size and forecast 2022-2027
  - Table Chart on South Africa - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on South Africa - Market size and forecast 2022-2027 ($ million)
  - Table Chart on South Africa - Year-over-year growth 2022-2027 (%)
  - Table Data Table on South Africa - Year-over-year growth 2022-2027 (%)
- Nigeria - Market size and forecast 2022-2027
  - Table Chart on Nigeria - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Nigeria - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Nigeria - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Nigeria - Year-over-year growth 2022-2027 (%)
- Kenya - Market size and forecast 2022-2027
  - Table Chart on Kenya - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Kenya - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Kenya - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Kenya - Year-over-year growth 2022-2027 (%)
- Uganda - Market size and forecast 2022-2027
  - Table Chart on Uganda - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Uganda - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Uganda - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Uganda - Year-over-year growth 2022-2027 (%)
- Rest of Africa - Market size and forecast 2022-2027
  - Table Chart on Rest of Africa - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Rest of Africa - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Rest of Africa - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of Africa - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Increasing prevalence of STDs
  - Favorable international programs
  - Government collaborations
- Market challenges
  - Lack of diagnosis of HIV and access to modern medication
  - Social stigma associated with STDs
  - High cost of novel antiviral therapeutics
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - Increase in awareness by various organizations
  - Growing focus on elimination of mother-to-child transmission of HIV
  - High HIV drug resistance
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- Abbott Laboratories
  - Table Abbott Laboratories - Overview
  - Table Abbott Laboratories - Business segments
  - Table Abbott Laboratories - Key news
  - Table Abbott Laboratories - Key offerings
  - Table Abbott Laboratories - Segment focus
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key offerings
- Alpha Pharma
  - Table Alpha Pharma - Overview
  - Table Alpha Pharma - Product / Service
  - Table Alpha Pharma - Key offerings
- Aspen Pharmacare Holdings Ltd.
  - Table Aspen Pharmacare Holdings Ltd. - Overview
  - Table Aspen Pharmacare Holdings Ltd. - Business segments
  - Table Aspen Pharmacare Holdings Ltd. - Key offerings
  - Table Aspen Pharmacare Holdings Ltd. - Segment focus
- AstraZeneca Plc
  - Table AstraZeneca Plc - Overview
  - Table AstraZeneca Plc - Product / Service
  - Table AstraZeneca Plc - Key news
  - Table AstraZeneca Plc - Key offerings
- Aurobindo Pharma Ltd.
  - Table Aurobindo Pharma Ltd. - Overview
  - Table Aurobindo Pharma Ltd. - Product / Service
  - Table Aurobindo Pharma Ltd. - Key offerings
- Avacare Health
  - Table Avacare Health - Overview
  - Table Avacare Health - Product / Service
  - Table Avacare Health - Key offerings
- Cipla Ltd.
  - Table Cipla Ltd. - Overview
  - Table Cipla Ltd. - Business segments
  - Table Cipla Ltd. - Key news
  - Table Cipla Ltd. - Key offerings
  - Table Cipla Ltd. - Segment focus
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- Gilead Sciences Inc.
  - Table Gilead Sciences Inc. - Overview
  - Table Gilead Sciences Inc. - Product / Service
  - Table Gilead Sciences Inc. - Key news
  - Table Gilead Sciences Inc. - Key offerings
- GlaxoSmithKline Plc
  - Table GlaxoSmithKline Plc - Overview
  - Table GlaxoSmithKline Plc - Business segments
  - Table GlaxoSmithKline Plc - Key offerings
  - Table GlaxoSmithKline Plc - Segment focus
- Merck and Co. Inc.
  - Table Merck and Co. Inc. - Overview
  - Table Merck and Co. Inc. - Business segments
  - Table Merck and Co. Inc. - Key news
  - Table Merck and Co. Inc. - Key offerings
  - Table Merck and Co. Inc. - Segment focus
- Sun Pharmaceutical Industries Ltd.
  - Table Sun Pharmaceutical Industries Ltd. - Overview
  - Table Sun Pharmaceutical Industries Ltd. - Product / Service
  - Table Sun Pharmaceutical Industries Ltd. - Key offerings
- Theratechnologies Inc.
  - Table Theratechnologies Inc. - Overview
  - Table Theratechnologies Inc. - Product / Service
  - Table Theratechnologies Inc. - Key offerings
- Viatris Inc.
  - Table Viatris Inc. - Overview
  - Table Viatris Inc. - Business segments
  - Table Viatris Inc. - Key offerings
  - Table Viatris Inc. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations